References
- 1The Centers for Disease Control and Prevention (CDC). Global Health – Indonesia. Centers for Disease Control and Prevention; 2021. Accessed September 20, 2022.
https://www.cdc.gov/globalhealth/countries/indonesia/pdf/indonesia-fs.pdf . - 2Indonesian Society of Nephrology. 11th Annual Report of Indonesian Renal Registry 2018. Bandung: Indonesian Society of Nephrology; 2018.
- 3Indonesian Ministry of Health. Indonesian Health Profile 2021. Jakarta: Indonesian Ministry of Health; 2021.
- 4Lydia A, Rachmaningrum G, Shatri H, Nugroho P. Factors associated with late referral in end stage renal disease patents at Dr. RSUPN Cipto Mangunkusumo Hospital. J. Penyakit Dalam Indones. 2020; 7(2): 110–116. DOI: 10.7454/jpdi.v7i2.433
- 5
The National Institute of Health Research and Development, Indonesian Ministry of Health . Laporan Riset Kesehatan Dasar (Riskesdas) 2007. Jakarta: Indonesian Ministry of Health; 2007. - 6
The National Institute of Health Research and Development, Indonesian Ministry of Health . Laporan Riset Kesehatan Dasar (Riskesdas) 2013. Jakarta: Indonesian Ministry of Health; 2013. - 7
The National Institute of Health Research and Development, Indonesian Ministry of Health . Laporan Riset Kesehatan Dasar (Riskesdas) 2018. Jakarta: Indonesian Ministry of Health; 2018. - 8Siswati T, Paramashanti BA, Rialihanto MP, Waris L. Epidemiological transition in Indonesia and its prevention: A narrative review. JOCAMR. 2022; 18(1): 50–60. DOI: 10.9734/jocamr/2022/v18i130345
- 9Hustrini NM, Susalit E, Rotmans JI. Prevalence and risk factors for chronic kidney disease in Indonesia: An analysis of the National Basic Health Survey 2018. J. Glob. Health. 2022; 12: 04074. DOI: 10.7189/jogh.12.04071
- 10Salman M, Khan AH, Adnan AS, et al. Attributable causes of chronic kidney disease in adults: A five-year retrospective study in a tertiary-care hospital in the northeast of the Malaysian Peninsula. Sao Paulo Med J. 2015; 133(6): 502–509. DOI: 10.1590/1516-3180.2015.005
- 11Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2022; 102(5S): S1–S127. DOI: 10.1016/j.kint.2022.06.008
- 12Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013; 3: 1–150.
- 13Persson F, Rossing P. Diagnosis of diabetic kidney disease: state of the art and future perspective. Kidney Int Suppl (2011). 2018; 8(1): 2–7. DOI: 10.1016/j.kisu.2017.10.003
- 14Radhakrishnan J.
Glomerular disease: Evaluation and differential diagnosis in adults . In: Glassock, RJ, Rovin, BH, Lam, AQ, (eds.), UpToDate, Post, TW (Ed). Waltham, MA: UpToDate; 2023. [cited: 2023 May 01]. Available from:https://www.uptodate.com/contents/glomerular-disease-evaluation-and-differential-diagnosis-in-adults?search=Glomerular%20disease:%20Evaluation%20and%20differential%20diagnosis%20in%20adults&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1 - 15Johansen KL, Chertow GM, Gilbertson DT, et al. US Renal Data System 2021 Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis. 2022; 79(4 suppl 1): Sviii–Sxi; S1-S575. DOI: 10.1053/j.ajkd.2022.02.001
- 16Huijben JA, Kramer A, Kerschbaum J, et al. Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA registry study. Nephrol Dial Transplant. 2022;1–14: gfac165. DOI: 10.1093/ndt/gfac165
- 17Zhao X, Niu Q, Gan L, et al. Baseline data report of the China Dialysis Outcomes and Practice Pattern Study (DOPPS). Sci Rep. 2021; 11: 873. DOI: 10.1038/s41598-020-79531-4
- 18Hemmelgarn BR, James MT, Manns BJ, et al. Rates of treated and untreated kidney failure in older vs younger adults. JAMA. 2012; 307(23): 2507–2515. DOI: 10.1001/jama.2012.6455
- 19Neild GH. Life expectancy with chronic kidney disease: an educational review. Pediatr Nephrol. 2017; 32: 243–248. DOI: 10.1007/s00467-016-3383-8
- 20Mahmood U, Healy HG, Kark A, et al. Spectrum (characteristics) of patients with chronic kidney disease (CKD) with increasing age in a major metropolitan renal service. BMC Nephrol. 2017; 18: 372. DOI: 10.1186/s12882-017-0781-5
- 21O’Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007; 18(10): 2758–2765. DOI: 10.1681/ASN.2007040422
- 22Elliot MJ, Tam-Tham H, Hemmelgarn BR; Alberta Kidney Disease Network. Age and treatment of kidney failure. Curr Opin Nephrol Hypertens. 2013; 22(3): 344–350. DOI: 10.1097/MNH.0b013e32835fe540
- 23Lai TS, Hsu CC, Lin MH, Wu VC, Chen YM. Trends in the incidence and prevalence of end-stage kidney disease requiring dialysis in Taiwan: 2010–2018. J Formos Med Assoc. 2022; 121(Suppl 1): S5–11. DOI: 10.1016/j.jfma.2021.12.013
- 24Bozorgmehri S, Aboud H, Chamarthi G, et al. Association of early initiation of dialysis with all-cause and cardiovascular mortality: A propensity score weighted analysis of the United States Renal Data System. Hemodial Int. 2021; 25(2): 188–197. DOI: 10.1111/hdi.12912
- 25Stel VS, Dekker FW, Ansell D, et al. Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant. 2009; 24(10): 3175–3182. DOI: 10.1093/ndt/gfp264
- 26Liu Y, Wang L, Han X, et al. The profile of timing dialysis initiation in patients with end-stage renal disease in China: A cohort study. Kidney Blood Press Res. 2020; 45: 180–193. DOI: 10.1159/000504671
- 27Hanafusa N, Fukagawa M. Global Dialysis Perspective: Japan. Kidney360. 2020; 1(5): 416–419. DOI: 10.34067/KID.0000162020
- 28Escoli R, Luz I, Santos P, Vila Lobos A. Glomerular filtration rate and initiation of dialysis. Ther Apher Dial. 2017; 21(6): 606–610. DOI: 10.1111/1744-9987.12582
- 29Umami V, Lydia A, Nainggolan G, Setiati S. Pengembangan model prediksi mortalitas 3 bulan pertama pada pasien penyakit ginjal kronik yang menjalani hemodialisis. J. Penyakit Dalam Indones. 2015; 2(3): 170–182. DOI: 10.7454/jpdi.v2i3.82
- 30Prodjosudjadi W. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia. Ethn Dis. 2006; 16(2 Suppl 2): S2-14–16.
- 31Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011; 8(4): 228–236. DOI: 10.1038/nrendo.2011.183
- 32Manne-Goehler J, Atun R, Stokes A, et al. Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries. Lancet Diabetes Endocrinol. 2016; 4(11): 903–912. DOI: 10.1016/S2213-8587(16)30181-4
- 33Hoogeveen EK. The Epidemiology of Diabetic Kidney Disease. Kidney Dial. 2022; 2: 433–442. DOI: 10.3390/kidneydial2030038
- 34Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria. Nephrology (Carlton). 2013; 18(8): 563–568. DOI: 10.1111/nep.12104
- 35Tesar V, Hruskova Z. Lupus Nephritis: A different disease in european patients? Kidney Dis (Basel). 2015; 1(2): 110–118. DOI: 10.1159/000438844
- 36Choi HS, Han KD, Jung JH, et al. The risk of end-stage renal disease in systemic lupus erythematosus: A nationwide population-based study in Korea. Medicine (Baltimore). 2019; 98(28):
e16420 . DOI: 10.1097/MD.0000000000016420 - 37Lydia A, Saraswati MH, Dharmeizar D, Saraswati M, Setiati S. Diagnostic determinants of proliferative lupus nephritis based on clinical and laboratory parameters: A diagnostic study. Acta Med Indones. 2018; 50(2): 110–118.
- 38Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021; 100(4S): S1–S276. DOI: 10.1016/j.kint.2021.05.021
- 39Indonesian Ministry of Health. National Formulary 2021. Jakarta: Indonesian Ministry of Health; 2021.
- 40Alexander, RT, Hemmelgarn, BR, Wiebe, N, et al; Alberta Kidney Disease Network. Kidney stones and kidney function loss: a cohort study. BMJ. 2012; 345:
e5287 . DOI: 10.1136/bmj.e5287 - 41Dhondup T, Kittanamongkolchai W, Vaughan LE, et al. Risk of ESRD and mortality in kidney and bladder stone formers. Am J Kidney Dis. 2018; 72(6): 790–797. DOI: 10.1053/j.ajkd.2018.06.012
- 42Liu Y, Chen Y, Liao B, et al. Epidemiology of urolithiasis in Asia. Asian J Urol. 2018; 5(4): 205–214. DOI: 10.1016/j.ajur.2018.08.007
- 43Paidi G, Iroshani Jayarathna AI, Salibindla DR, et al. Chronic kidney disease of unknown origin: A mysterious epidemic. Cureus. 2021; 13(8):
e17132 . DOI: 10.7759/cureus.17132 - 44Fitria L, Prihartono NA, Ramdhan DH, Wahyono TYM, Kongtip P, Woskie S. Environmental and occupational risk factors associated with chronic kidney disease of unknown etiology in West Javanese rice farmers, Indonesia. Int J Environ Res Public Health. 2020; 17(12): 4521. DOI: 10.3390/ijerph17124521
